Multidisciplinary Approach to Retroperitoneal Sarcomas

“Decoding GI-HPB Oncology”
01 June 2022, Wednesday, 7 PM
Webisode 36: Retroperitoneal Sarcomas
Session (1/2): Multidisciplinary Approach to Retroperitoneal Sarcomas
Program details
1. Evidence based approach: Dr. Sameer Rastogi
2. Case based panel discussion: Dr. Devavrat Arya
Panelists:
Dr. Sameer Rastogi
Dr. Nehal Khanna
Dr. Udip Maheshwari
Dr. Sujeet Bhat
Details and registration: gioncology.in

[@khaliddurrani6432]

Thanks to the organizers and the panelists for a comprehensive and insightful ( though non-surgical )discussion of RPS. As of the case ( presented ) the histology and the grade would determine the course of management. To conclude Radiation except for WD & G1 LPS ( may increase the chances of R0 resection) has probably no role in lieomyosarcoma wherein neo Adj chemo would certainly be beneficial. Respected speakers have not elaborated the use of pre-op chemo with hyperthermia is selected tumors ( a standard practice In German sarcoma centers)

[@khaliddurrani6432]

It appears that STRASS trial failed to show any significant survival benefit for radiation. However well differentiated LPS had lower local recurrence vs de-differentiated type. Post op is radiation is as well of doubtful value. STRASS 2 may be able to answer the role neo-Adj chemo.